Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mixture of seven synthetic fragments consisting of p21 RAS peptides

EU orphan designation number: EU/3/11/885   
Active ingredient: Mixture of seven synthetic fragments consisting of p21 RAS peptides
Indication: Treatment of pancreatic cancer
Sponsor: Targovax ASA
Lilleakerveien 2C, 0283 Oslo, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/08/2011 Orphan designation EMA/OD/007/11 (2011)5810 of 05/08/2011
05/10/2016 Change of name and/or address of sponsor EMA/OD/007/11